DoctorRachel Atkinson

Lecturer in Dementia Studies

Wicking Dementia Research Education Centre

  • Lecturer in Dementia Studies
    Wicking Dementia Research Education Centre
  • +61 3 6226 4278 (Work)
  • Wicking Dementia Research Education Centre, Wicking Dementia Research and Education Centre, 417-22, Level 4 Medical Science 1, Hobart CBD Campuses, TAS

RESEARCH SUMMARy

Rachel’s research aligns to the University’s research theme of Better Health and with the NHMRA priority areas of Dementia and Ageing Well. As a member of the Wicking Centre, her research is targeted towards better understanding of the cellular and molecular mechanisms which underpin dementia. Rachel’s particular interests include understanding the underlying causes of frontotemporal dementia and amyotrophic lateral sclerosis.

Frontotemporal dementia is the second most common cause of younger onset dementia, and amyotrophic lateral sclerosis is the most common form of motor neuron disease. A number of proteins have been implicated in playing roles in these diseases. Rachel’s research proposes that these proteins play a role in maintaining the long nerve processes of neurons, and, in disease this results in disconnection of neurons within the nervous system. In order to study these proteins, Rachel uses viruses, like those that infect humans, to inject cells in the brain and in the dish and cause them to express mutant forms of proteins involved in frontotemporal dementia and amyotrophic lateral sclerosis. These techniques allow the mechanisms by which these proteins cause nerve cells to dysfunction to be further deciphered.

Expertise:
Tissue Culture (primary mouse and stem cell)
Molecular Biology (cloning) and construct design
Viral techniques
Behavioural studies in mice
Advanced microscopy

FUNDED PROJECTS

  • GRANT
    Optogenetic models of TDP-43 proteinopathy in MND
    1 Jan 2026 - 31 Dec 2026
    People funded by this grant:
    • Reading A,
    • Lin J,
    • Phipps A,
    • Atkinson R,
    • Cook T
    Project Total: $99,921; The nuclear loss, and concomitant cytoplasmic accumulation of TDP-43 in motor neurons is a hallmark of amyotrophic lateral sclerosis (ALS) the most common form of motor neuron disease (MND). The contribution of each mislocalization, aggregation and nuclear loss-of-function to toxicity and disease progression is still being elucidated, but it is clear that disease progression is multifaceted. This project will further develop two novel optogenetic tools generated by our lab, which drive inducible and reversible TDP-43 proteinopathy either by TDP-43 aggregation, or mislocalisation respectively. While these tools stand as first iteration designs, both visually demonstrate robust induction of the intended proteinopathy. Based on these preliminary data we intend to 1) enhance this effect through rational modification of the protein design, and 2) functionally characterize this induced proteinopathy, demonstrating their disease relevance. The first 2 aims of this project will address these two points. The third aim of the project will utilize these tools to compare the effects of mislocalisation and aggregation on ALS disease progression in an iPSC-derived cortical neuron culture paradigm. Being the first to delineate the effect of these two facets of pathology, whilst simultaneously demonstrating these tool and culture paradigm as a bona-fide novel model of TDP-43-driven ALS. At the completion of this project, we will have two powerful and novel methods of controlling TDP-43 proteinopathy; models which allow inducible and reversible control, that will expand the bounds of current ALS research. Funded by: MND Australia - Innovator ($99,921); University of Tasmania.
  • GRANT
    Protecting against axon degeneration in MND
    1 Jan 2025 - 31 Mar 2026
    People funded by this grant:
    • Phipps A,
    • King A,
    • Atkinson R,
    • Collins J,
    • Thorne B
    Project Total: $100,000; In MND, motor nerve cells become hyperactive, which leads to the release of molecules that become toxic to the nervous system environment, including the long fibres that connect between nerve cells and our muscles. We have identified a range of changes that occur to the nerve cell fibres that contribute to their degeneration after nerve cells become hyperactive and aim to counteract the changes to prevent the fibres from degeneration in MND. This project will test molecules to prevent nerve fibre degeneration in MND, and provide a pathway to preclinical drug development for MND. Funded by: Motor Neurone Disease Research Australia - Grant - Innovator ($100,000); University of Tasmania.
  • GRANT
    Understanding Axon degeneration in MND
    1 Jan 2025 - 31 Dec 2025
    People funded by this grant:
    • Phipps A,
    • King A,
    • Atkinson R,
    • Clark R,
    • Wilson R
    Project Total: $30,000; The nervous system is connected by wiring, which is critical for controlling how we move, think and control bodily functions. This wiring is composed of neuronal structures called axons which in humans can be over a metre long. Like electrical wiring, any dysfunction or degeneration of the axons can completely prevent neuronal communication resulting in inability to move or think. Loss of wiring (axon degeneration) is a defining feature of motor neuron diseases (MND). This grant seeks to understand axon alterations in MND at the molecular level in order to develop axon-specific therapeutic strategies. Critical to this is understanding axonal alterations in human MND tissue. There have been few studies examining this, despite substantial evidence of the importance of axon loss in MND. In this project we will identify axonal alterations from upper and lower motor neurons in human MND cases using techniques such as transcriptomics and proteomics, which enable unbiased, high throughput screening of potential pathways that contribute to axon degeneration in MND. We will determine whether axons vulnerable in MND exhibit unique molecular properties that drive their degeneration and aim to determine how alterations in vulnerable upper and lower axon tracts are distinct from less vulnerable sensory axon tracts in human MND tissue. Funded by: Donation via Menzies Institute for Medical Research - Donation ($30,000); University of Tasmania.
  • GRANT
    The Cellular Consequences of Oligogenic/Polygenic Inheritance in ALS
    1 Oct 2024 - 30 Sep 2027
    People funded by this grant:
    • Cook T,
    • Thorne B,
    • King A,
    • Perry S,
    • Atkinson R
    Project Total: $996,179; ALS is often considered as being either familial (inherited within a family), or sporadic and of unclear origin. However, for sporadic disease the most common form of ALS there are clear genetic risks that, for some people, include variants in multiple genes that act together to increase risk of disease. Most studies seeking to understand the genetic contribution to ALS study one gene at time. While we have learnt much from this approach, a considerable gap in our knowledge is how combinations of genes that increase risk for ALS change how nerve cells are organised and how they function. This project is specifically designed to bridge this gap. To achieve this, we will compare how specific variant gene combinations that occur in people with ALS alter the biology of nerve cells, generated in the laboratory from human stem cells. We will measure changes to nerve cell organisation and function, use multiple technologies that include unbiased surveys that capture highly detailed information about structures within nerve cells, and the genes they activate to produce and change these structures. This will enable us to identify the key cellular changes that occur as cells become increasingly vulnerable to specific gene combinations, and in turn, help us understand how ALS develops. Funded by: FightMND - Grant-Discovery ($996,178); University of Tasmania.
  • GRANT
    Freezing MND in its tracks
    18 Mar 2024 - 18 Oct 2027
    People funded by this grant:
    • Atkinson R
    Project Total: $350,000; This project aims to establish whether modulation of cold shock pathways could be an effective therapeutic target for amyotrophic lateral sclerosis. Funded by: Motor Neurone Disease Australia Limited - Fellowship-Postdoctoral Research ($100,000); Motor Neurone Disease Research Australia ($250,000); University of Tasmania ($141,474).
  • GRANT
    Brian Marks Research Grant: A human stem-cell derived model of the neuro-muscular junction to investigate axonal alterations caused by C9ORF72 pathogenic repeat expansion
    1 Jan 2023 - 21 Apr 2026
    People funded by this grant:
    • Atkinson R
    Project Total: $30,000; Donation account for Brian Marks Research Grant recipient. Funded by: Donation via University of Tasmania Foundation - Donation ($30,000); University of Tasmania.
  • GRANT
    Siganto Foundation HDR student Career Development Scholarship in dementia research
    1 Jan 2023 - 1 Jul 2025
    People funded by this grant:
    • Phipps A,
    • Dixit D,
    • King A,
    • Atkinson R
    Project Total: $10,000; Training and building collaborations for techniques involving super resolution microscopy (SRM) and applying these techniques to induced pluripotent stem-cell (iPSC) derived neurons and post-mortem human tissue, at the University of Cambridge, UK. Funded by: Siganto Foundation - Donation ($10,000); University of Tasmania.
  • GRANT
    Epidemiology in a dish: using human iPSC to discover common and genotype-specific molecular signatures of the multi-step hypothesis of ALS
    1 Sep 2022 - 31 Mar 2026
    People funded by this grant:
    • Cook T,
    • Perry S,
    • King A,
    • Atkinson R,
    • Phipps A
    Project Total: $999,981; In this project we want to investigate whether genetic risk and environmental interactions cause motor neurons to die and what cellular pathways are activated in response to genetic and environmental risk individually, and combined. We will use human cells to grow motor neurons in a dish, and genetically alter these neurons to carry genes associated with familial or sporadic ALS - this will be modelling the first 'step' in the multistep process. We will then expose these neurons to a variety of environmental factors known to be risk factors for ALS, including cholesterol, neurotoxins and increased cellular activity, that will contribute additional steps in this process. We will examine how the neurons respond to different gene-environment interactions by documenting changes to their shape, activity and function, cellular processes and protein expression, to identify key/signature pathways in these cells that are going wrong in disease. We will correlate our findings in cells to human ALS tissues and ALS mouse models. This work will help us understand how ALS develops and why cells are vulnerable to genetic and environmental interactions. Funded by: FightMND - Grant-Discovery ($999,981); University of Tasmania.
  • GRANT
    To die or not to die: What is the mechanism of axon degeneration in ALS?
    1 Jan 2022 - 30 Jun 2023
    People funded by this grant:
    • Phipps A,
    • Atkinson R,
    • Perry S,
    • King A,
    • Cook T
    Project Total: $99,491; Axons are long processes that allow for communication between our nerve cells and muscles to enable movement. During MND, nerve cell axons degenerate, leading to loss of motor function and mortality; the mechanism of which we do not understand. In this project, we will use human iPSC-derived nerve cells to investigate what pathways are involved in axon degeneration through 'omics' approaches, including RNA-seq and proteomics. By understanding why axons are vulnerable, and what pathways dysfunction during MND, we can design novel therapies to prevent and treat axon degeneration in MND. Funded by: Motor Neurone Disease Research Australia - Grant - Innovator ($99,491); University of Tasmania.
  • GRANT
    A potential metabolic-targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin
    15 Sep 2019 - 31 Dec 2023
    People funded by this grant:
    • Fernandez Martos C,
    • King A,
    • Del Olmo Izquierdo N,
    • Sreedharan J,
    • Vickers J
    Project Total: $222,212; This project looks at the effect of leptin resistance induced by high path diet on the neurodegenerative pathways induced by TDP-43. Funded by: Fundacion Hospital Nacional de Paraplejicos - Consortium Agreement; University of Tasmania.
  • GRANT
    Do Renshaw cells have a role in amyotrophic lateral sclerosis disease progression
    1 May 2019 - 31 Dec 2019
    People funded by this grant:
    • Perry S,
    • Atkinson R,
    • King A
    Project Total: $15,814; Amyotrophic lateral sclerosis (ALS) is a debilitating disease that results in the degeneration and eventual death of motor neurons in the brain and spinal cord. Currently, there are no effective treatments to slow or stop disease progression, and as such, patients experience a rapid progression of deteriorating motor symptoms prior to their death. We do not have a solid understanding of what causes motor neurons to be especially vulnerable to degeneration, however, we know that an increase in motor neuron activity, drives the disease forward. To better understand why motor neurons are targeted to become over active, we need to broaden our investigation of ALS mechanisms to other cell populations within motor circuits to examine how these cells might contribute to the biological mechanisms causing the disease. This project focuses on investigating how a population of spinal cord cells, known as Renshaw cells, might contribute to motor neuron degeneration and ALS disease mechanisms. We will use experimental mouse models that i) target Renshaw cells and ii) mimic ALS disease processes, and establish novel techniques to grow spinal cord cells in a dish. We will use these methods to identify and investigate the vulnerability and degeneration of Renshaw cells in response to ALS disease mechanisms, and what consequence this has on motor neuron degeneration. Funded by: University of Tasmania - Grant-Research Enhancement Program; University of Tasmania ($15,814).
  • GRANT
    Proteomic analysis of exosomes from iPS cell-derived neurons with mislocalised TDP-43
    1 Jan 2019 - 1 Jan 2020
    People funded by this grant:
    • Cook T,
    • King A,
    • Atkinson R,
    • Perry S,
    • Hewitt A
    Project Total: $99,665; Our overarching hypothesis is that TDP-43 mislocalisation leads to altered axonal and exosomal protein expression, and which may underpin the mechanism of TDP-43 pathological spread leading to neurodegeneration of motor circuits in ALS. To begin testing this hypothesis, we have designed experiments to address three Specific Aims: Aim 1: To characterize human iPS cell-based models of TDP-43 mislocalisation Aim 2: To quantify proteins differentially expressed in axons and exosomes of iPS cell-derived neurons with and without TDP-43 mislocalisation Aim 3: To quantify transmission of TDP-43 mislocalisation and altered phosphorylation in a human cerebral organoid model Funded by: Motor Neurone Disease Research Australia - Grant - Innovator ($99,665); University of Tasmania.
  • GRANT
    The role of FTLD proteins in neurite health, function and dysfunction
    1 Mar 2014 - 1 Mar 2017
    People funded by this grant:
    • King A,
    • Atkinson R,
    • Vickers J
    Project Total: $90,000; In the last seven years a number of proteins have been identified that are pathologically or genetically associated with Frontotemporal Lobe Degeneration including TDP-43, FUS, C9ORF72 and progranulin. As ubiquitously expressed proteins it has been difficult to assess the role these proteins play in disease, particularly associated with ageing. This project proposes that the disease-associated roles are likely to stem from functions that are specific to neurons and/or glial cells. Accumulating evidence suggests that many of these proteins are involved in neurite outgrowth and cytoskeletal maintenance. This project will use a threefold approach to investigate the role of FTLD proteins in disease. First, it will utilize novel primary cell culture techniques that allow compartmentalization of the neuron to probe axonal and somatodenditic mechanisms. Second, it will utilize an in-vivo intraocular injection model to rapidly examine the effect of mutant and non-mutant proteins on downstream connectivity. Finally, it will investigate neurite pathology in human tissue. This project will provide mechanistic insight into the role of FTLD proteins in disease. Funded by: Dementia Australia Research Foundation Ltd - Grant-Scholarship ($90,000); University of Tasmania ($25,122).